All Episodes

May 2, 2023 36 mins
Dr. Li-Meng Yan or Yan Limeng; is a Chinese virologist, known for her publications and interviews alleging that SARS-CoV-2 was made in a Chinese government laboratory. Her publications have been widely dismissed as flawed by the scientific community. In April 2020, she fled to the United States. She co-authored several preprint research papers claiming that SARS-CoV-2 was "produced in a laboratory. Between September 2020 and March 2021, Yan authored a series of four preprint research papers, wherein she argued that SARS-CoV-2 did not emerge naturally in a "spillover from animals," but rather was produced in a laboratory. Her preprints (which did not undergo a scientific peer review process) were posted to the Zenodo platform, an open-access repository where anyone can post their research. Yan stated that evidence of genetic engineering was censored in scientific journals, allegedly as part of a conspiracy to suppress information on the topic. However, other scientists disputed the validity of the papers, pointing to poor methods, undisclosed funding from politically-motivated sources, the use of pseudonyms for the papers' co-authors, and the papers having never been submitted to a journal for review. Join national political commentator/host Chauncey I. Brown III and Dr. Li-Meng Yan as she explains her findings. Please consider making a donation so we may continue to be a voice for the silent majority.. Thank you for your continued support.
Mark as Played

Advertise With Us

Popular Podcasts

Dateline NBC
Death, Sex & Money

Death, Sex & Money

Anna Sale explores the big questions and hard choices that are often left out of polite conversation.

Stuff You Should Know

Stuff You Should Know

If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

© 2024 iHeartMedia, Inc.